Geneos Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.34K Sell
557
-10
-2% -$75 ﹤0.01% 2234
2025
Q4
$4.07K Sell
567
-50
-8% -$395 ﹤0.01% 2196
2025
Q3
$6.59K Sell
617
-1,234
-67% -$12.1K ﹤0.01% 2079
2025
Q2
$17.9K Sell
1,851
-1,054
-36% -$10.9K ﹤0.01% 2082
2025
Q1
$82.7K Buy
2,905
+1,601
+123% +$24.6K ﹤0.01% 1664
2024
Q4
$19.5K Sell
1,304
-105
-7% -$1.71K ﹤0.01% 1737
2024
Q3
$26.9K Buy
1,409
+953
+209% +$19.8K ﹤0.01% 1436
2024
Q2
$9.44K Buy
456
+47
+11% +$934 ﹤0.01% 1565
2024
Q1
$7.68K Hold
409
﹤0.01% 1606
2023
Q4
$5.9K Sell
409
-152
-27% -$2.07K ﹤0.01% 1689
2023
Q3
$9.74K Sell
561
-206
-27% -$4.29K ﹤0.01% 1574
2023
Q2
$16K Buy
767
+1
+0.1% +$22 ﹤0.01% 1446
2023
Q1
$18K Sell
766
-73
-9% -$1.96K ﹤0.01% 1379
2022
Q4
$23.4K Buy
839
+40
+5% +$1.02K ﹤0.01% 1284
2022
Q3
$18K Sell
799
-2,952
-79% -$89.1K ﹤0.01% 1359
2022
Q2
$128K Sell
3,751
-16
-0.4% -$560 0.01% 912
2022
Q1
$131K Buy
+3,767
New +$129K 0.01% 977

Other funds holding OGN

Geneos Wealth Management's OGN Position: Q1 2026 in Review

Geneos Wealth Management reduced its Organon & Co (OGN) stake by 1.8% in Q1 2026, selling an estimated $75 and leaving 557 shares worth $3.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

Geneos Wealth Management first reported a position in OGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $131K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Geneos Wealth Management held 557 shares of Organon & Co worth $3.34K as of Q1 2026.
  • Geneos Wealth Management sold 10 Organon & Co shares in Q1 2026, an estimated $75.
  • Organon & Co made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2234 holding.
  • Geneos Wealth Management first reported a position in Organon & Co in Q1 2022 and has held it in 17 quarters since.
  • Geneos Wealth Management's Organon & Co position peaked at $131K in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.